S&P 500   4,649.80 (+1.20%)
DOW   35,083.42 (+0.53%)
QQQ   397.67 (+1.65%)
AAPL   159.59 (+1.77%)
MSFT   337.21 (+2.28%)
FB   337.05 (+1.18%)
GOOGL   2,903.04 (+2.09%)
AMZN   3,572.53 (+1.94%)
TSLA   1,133.37 (+4.76%)
NVDA   326.36 (+3.60%)
BABA   131.93 (-1.06%)
NIO   39.70 (-0.73%)
CGC   11.04 (-5.56%)
AMD   158.44 (+2.34%)
GE   96.99 (-0.87%)
MU   84.52 (+1.32%)
T   23.91 (-1.28%)
F   19.61 (-0.71%)
DIS   144.36 (-2.53%)
ACB   6.44 (-5.15%)
AMC   36.20 (-3.80%)
PFE   53.93 (-0.13%)
BA   195.83 (-1.70%)
S&P 500   4,649.80 (+1.20%)
DOW   35,083.42 (+0.53%)
QQQ   397.67 (+1.65%)
AAPL   159.59 (+1.77%)
MSFT   337.21 (+2.28%)
FB   337.05 (+1.18%)
GOOGL   2,903.04 (+2.09%)
AMZN   3,572.53 (+1.94%)
TSLA   1,133.37 (+4.76%)
NVDA   326.36 (+3.60%)
BABA   131.93 (-1.06%)
NIO   39.70 (-0.73%)
CGC   11.04 (-5.56%)
AMD   158.44 (+2.34%)
GE   96.99 (-0.87%)
MU   84.52 (+1.32%)
T   23.91 (-1.28%)
F   19.61 (-0.71%)
DIS   144.36 (-2.53%)
ACB   6.44 (-5.15%)
AMC   36.20 (-3.80%)
PFE   53.93 (-0.13%)
BA   195.83 (-1.70%)
S&P 500   4,649.80 (+1.20%)
DOW   35,083.42 (+0.53%)
QQQ   397.67 (+1.65%)
AAPL   159.59 (+1.77%)
MSFT   337.21 (+2.28%)
FB   337.05 (+1.18%)
GOOGL   2,903.04 (+2.09%)
AMZN   3,572.53 (+1.94%)
TSLA   1,133.37 (+4.76%)
NVDA   326.36 (+3.60%)
BABA   131.93 (-1.06%)
NIO   39.70 (-0.73%)
CGC   11.04 (-5.56%)
AMD   158.44 (+2.34%)
GE   96.99 (-0.87%)
MU   84.52 (+1.32%)
T   23.91 (-1.28%)
F   19.61 (-0.71%)
DIS   144.36 (-2.53%)
ACB   6.44 (-5.15%)
AMC   36.20 (-3.80%)
PFE   53.93 (-0.13%)
BA   195.83 (-1.70%)
S&P 500   4,649.80 (+1.20%)
DOW   35,083.42 (+0.53%)
QQQ   397.67 (+1.65%)
AAPL   159.59 (+1.77%)
MSFT   337.21 (+2.28%)
FB   337.05 (+1.18%)
GOOGL   2,903.04 (+2.09%)
AMZN   3,572.53 (+1.94%)
TSLA   1,133.37 (+4.76%)
NVDA   326.36 (+3.60%)
BABA   131.93 (-1.06%)
NIO   39.70 (-0.73%)
CGC   11.04 (-5.56%)
AMD   158.44 (+2.34%)
GE   96.99 (-0.87%)
MU   84.52 (+1.32%)
T   23.91 (-1.28%)
F   19.61 (-0.71%)
DIS   144.36 (-2.53%)
ACB   6.44 (-5.15%)
AMC   36.20 (-3.80%)
PFE   53.93 (-0.13%)
BA   195.83 (-1.70%)
NASDAQ:NEPT

Neptune Wellness Solutions Stock Forecast, Price & News

$0.50
+0.00 (+0.10%)
(As of 11/29/2021 11:32 AM ET)
Add
Compare
Today's Range
$0.50
$0.51
50-Day Range
$0.48
$0.62
52-Week Range
$0.47
$3.60
Volume
9,800 shs
Average Volume
3.12 million shs
Market Capitalization
$83.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.27
30 days | 90 days | 365 days | Advanced Chart
Receive NEPT News and Ratings via Email

Sign-up to receive the latest news and ratings for Neptune Wellness Solutions and its competitors with MarketBeat's FREE daily newsletter.


Neptune Wellness Solutions logo

About Neptune Wellness Solutions

Neptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NEPT
Employees
58
Year Founded
N/A

Sales & Book Value

Annual Sales
$35.45 million
Book Value
$0.80 per share

Profitability

Net Income
$-126.68 million
Net Margins
-344.98%
Pretax Margin
-358.64%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$83.74 million
Optionable
Optionable

Company Calendar

Last Earnings
11/15/2021
Today
11/29/2021
Next Earnings (Estimated)
2/21/2022
Fiscal Year End
3/31/2022

MarketRank

Overall MarketRank

1.78 out of 5 stars

Medical Sector

841st out of 1,392 stocks

Pharmaceutical Preparations Industry

404th out of 670 stocks

Analyst Opinion: 3.3Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -












Neptune Wellness Solutions (NASDAQ:NEPT) Frequently Asked Questions

Is Neptune Wellness Solutions a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Neptune Wellness Solutions stock.
View analyst ratings for Neptune Wellness Solutions
or view top-rated stocks.

How has Neptune Wellness Solutions' stock price been impacted by Coronavirus?

Neptune Wellness Solutions' stock was trading at $1.21 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NEPT shares have decreased by 58.6% and is now trading at $0.5005.
View which stocks have been most impacted by COVID-19
.

When is Neptune Wellness Solutions' next earnings date?

Neptune Wellness Solutions is scheduled to release its next quarterly earnings announcement on Monday, February 21st 2022.
View our earnings forecast for Neptune Wellness Solutions
.

How were Neptune Wellness Solutions' earnings last quarter?

Neptune Wellness Solutions Inc (NASDAQ:NEPT) posted its quarterly earnings data on Monday, November, 15th. The biotechnology company reported ($0.09) EPS for the quarter, hitting analysts' consensus estimates of ($0.09). The biotechnology company had revenue of $12.50 million for the quarter, compared to analyst estimates of $10.99 million. Neptune Wellness Solutions had a negative net margin of 344.98% and a negative trailing twelve-month return on equity of 74.86%.
View Neptune Wellness Solutions' earnings history
.

What price target have analysts set for NEPT?

2 Wall Street analysts have issued 1-year price targets for Neptune Wellness Solutions' shares. Their forecasts range from $0.75 to $1.50. On average, they expect Neptune Wellness Solutions' share price to reach $1.13 in the next twelve months. This suggests a possible upside of 124.8% from the stock's current price.
View analysts' price targets for Neptune Wellness Solutions
or view top-rated stocks among Wall Street analysts.

Who are Neptune Wellness Solutions' key executives?

Neptune Wellness Solutions' management team includes the following people:
  • Mr. James S. Hamilton, Pres, CEO & Director
  • Mr. Mario Paradis, VP & CFO
  • Mr. Marc Vaugeois, VP of Sales
  • Mr. Michel Timperio, Pres of Cannabis Bus.
  • Mr. François-Karl Brouillette, VP of Science & Innovation of Nutraceutical Bus.

What other stocks do shareholders of Neptune Wellness Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include (CGC), Tilray (TLRY), Aurora Cannabis (ACB), Cronos Group (CRON), (APHA), Cara Therapeutics (CARA), Innovative Industrial Properties (IIPR), Zynerba Pharmaceuticals (ZYNE), Amarin (AMRN) and NewAge (NBEV).

What is Neptune Wellness Solutions' stock symbol?

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

Who are Neptune Wellness Solutions' major shareholders?

Neptune Wellness Solutions' stock is owned by many different institutional and retail investors. Top institutional shareholders include Goldman Sachs Group Inc. (1.80%), Penserra Capital Management LLC (1.44%), Commonwealth Equity Services LLC (0.69%), Morgan Stanley (0.30%), Natixis (0.07%) and Citadel Advisors LLC (0.00%).

Which major investors are selling Neptune Wellness Solutions stock?

NEPT stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, Wolverine Trading LLC, and Millennium Management LLC.

Which major investors are buying Neptune Wellness Solutions stock?

NEPT stock was bought by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Penserra Capital Management LLC, Commonwealth Equity Services LLC, Morgan Stanley, and Natixis.

How do I buy shares of Neptune Wellness Solutions?

Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Neptune Wellness Solutions' stock price today?

One share of NEPT stock can currently be purchased for approximately $0.50.

How much money does Neptune Wellness Solutions make?

Neptune Wellness Solutions has a market capitalization of $83.74 million and generates $35.45 million in revenue each year. The biotechnology company earns $-126.68 million in net income (profit) each year or ($1.02) on an earnings per share basis.

How many employees does Neptune Wellness Solutions have?

Neptune Wellness Solutions employs 58 workers across the globe.

What is Neptune Wellness Solutions' official website?

The official website for Neptune Wellness Solutions is www.neptunecorp.com.

Where are Neptune Wellness Solutions' headquarters?

Neptune Wellness Solutions is headquartered at 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3.

How can I contact Neptune Wellness Solutions?

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262, via email at [email protected], or via fax at 45-0687-2272.


This page was last updated on 11/29/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.